Report Scope:
The report provides a comprehensive summary of the Non-injectable insulin market, along with detailed profiles of key market players that include revenue product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. The report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size. The report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. The study segments the market according to applications and end-uses. Geographical market analysis is provided for all major segments.
The Report Includes:
- An overview of the global market for non-injectable insulin
- Analyses of market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information on recent major technical advances in different forms of non-injectable insulin
- A look at the key areas of growth and adoption rate of non-injectable insulin among both commercial customers and regulatory authorities
- Examination of strategies of the major players in the market and the impact of new technological developments
Table of Contents
Samples
LOADING...
Executive Summary
This comprehensive report provides an in-depth assessment of the global market for Non-injectable insulin. The report’s key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of Non-injectable insulin in developed and emerging markets.
This report details recent key technical advances in different forms of Non-injectable insulin, as well as the adoption rate among both commercial customers and regulatory authorities. The report intends to identify key areas of growth. The report also studies the key strategies of major players in the market and the impact of new technological developments.
Companies Mentioned
- Access Pharmaceuticals Inc. (Abeona Therapeutics Inc.)
- Aerami Therapeutics
- Biocon Ltd.
- Biodel Inc. (Albireo Ltd.)
- Bionova Lifesciences
- Boston Therapeutics Inc.
- Coromed Inc.
- Diabetology Ltd.
- Diasome Pharmaceuticals Inc.
- Emisphere Technologies Inc.
- Generex Biotechnology Corp.
- Midatech Pharma Plc
- Oramed Pharmaceuticals Inc.
- Rani Therapeutics
- Shreya Life Sciences Pvt. Ltd.
![Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)), End User (Hospitals & Clinics, Patients/Homecare) - Forecast to 2028 - Product Image](http://www.researchandmarkets.com/product_images/12534/12534941_60px_jpg/global_insulin_delivery_devices_market.jpg)
